|
1
|
Gill S and Sinicrope FA: Colorectal cancer
prevention: Is an ounce of prevention worth a pound of cure? Semin
Oncol. 32:24–34. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chinery R, Beauchamp RD, Shyr Y, Kirkland
SC, Coffey RJ and Morrow JD: Antioxidants reduce cyclooxygenase-2
expression, prostaglandin production, and proliferation in
colorectal cancer cells. Cancer Res. 58:2323–2327. 1998.PubMed/NCBI
|
|
3
|
Wang J, Yang Y, Xia HH, Gu Q, Lin MC,
Jiang B, Peng Y, Li G, An X, Zhang Y, et al: Suppression of FHL2
expression induces cell differentiation and inhibits gastric and
colon carcinogenesis. Gastroenterology. 132:1066–1076. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu Q, Wang JD, Xia HH, Lin MC, He H, Zou
B, Tu SP, Yang Y, Liu XG, Lam SK, et al: Activation of the
caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in
gastric cancer. Carcinogenesis. 26:541–546. 2005. View Article : Google Scholar
|
|
5
|
He H, Xia HH, Wang JD, Gu Q, Lin MC, Zou
B, Lam SK, Chan AO, Yuen MF, Kung HF, et al: Inhibition of human
telomerase reverse transcriptase by nonsteroidal antiinflammatory
drugs in colon carcinoma. Cancer. 106:1243–1249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Capozzi E, Della Puppa L, Fornasarig M,
Pedroni M, Boiocchi M and Viel A: Evaluation of the replication
error phenotype in relation to molecular and clinicopathological
features in hereditary and early onset colorectal cancer. Eur J
Cancer. 35:289–295. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sinicrope FA and Sugarman SM: Role of
adjuvant therapy in surgically resected colorectal carcinoma.
Gastroenterology. 109:984–993. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim IJ, Ku JL, Kang HC, Park JH, Yoon KA,
Shin Y, Park HW, Jang SG, Lim SK, Han SY, et al: Mutational
analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal
cancer patients: R154H OGG1 polymorphism is associated with
sporadic colorectal cancer patients. Hum Genet. 115:498–503. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Liang L, Huang L, Ma X, Li D and Cai
S: High expression of protein phosphatase 4 is associated with the
aggressive malignant behavior of colorectal carcinoma. Mol Cancer.
14:952015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maroney AC, Qureshi SA, Foster DA and
Brugge JS: Cloning and characterization of a thermolabile v-src
gene for use in reversible transformation of mammalian cells.
Oncogene. 7:1207–1214. 1992.PubMed/NCBI
|
|
11
|
Liu W, Yue F, Zheng M, Merlot A, Bae DH,
Huang M, Lane D, Jansson P, Lui GY, Richardson V, et al: The
proto-oncogene c-Src and its downstream signaling pathways are
inhibited by the metastasis suppressor, NDRG1. Oncotarget.
6:8851–8874. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burger KL, Learman BS, Boucherle AK,
Sirintrapun SJ, Isom S, Díaz B, Courtneidge SA and Seals DF:
Src-dependent Tks5 phosphorylation regulates invadopodia-associated
invasion in prostate cancer cells. Prostate. 74:134–148. 2014.
View Article : Google Scholar
|
|
13
|
Baker AM, Cox TR, Bird D, Lang G, Murray
GI, Sun XF, Southall SM, Wilson JR and Erler JT: The role of lysyl
oxidase in SRC-dependent proliferation and metastasis of colorectal
cancer. J Natl Cancer Inst. 103:407–424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Di Stefano P, Cabodi S, Boeri Erba E,
Margaria V, Bergatto E, Giuffrida MG, Silengo L, Tarone G, Turco E
and Defilippi P: P130Cas-associated protein (p140Cap) as a new
tyrosine-phosphorylated protein involved in cell spreading. Mol
Biol Cell. 15:787–800. 2004. View Article : Google Scholar :
|
|
15
|
Damiano L, Le Dévédec SE, Di Stefano P,
Repetto D, Lalai R, Truong H, Xiong JL, Danen EH, Yan K, Verbeek
FJ, et al: p140Cap suppresses the invasive properties of highly
metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.
Oncogene. 31:624–633. 2012.
|
|
16
|
Damiano L, Di Stefano P, Camacho Leal MP,
Barba M, Mainiero F, Cabodi S, Tordella L, Sapino A, Castellano I,
Canel M, et al: p140Cap dual regulation of E-cadherin/EGFR
cross-talk and Ras signalling in tumour cell scatter and
proliferation. Oncogene. 29:3677–3690. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharma N, Repetto D, Aramu S, Grasso S,
Russo I, Fiorentino A, Mello-Grand M, Cabodi S, Singh V, Chiorino
G, et al: Identification of two regions in the p140Cap adaptor
protein that retain the ability to suppress tumor cell properties.
Am J Cancer Res. 3:290–301. 2013.PubMed/NCBI
|
|
18
|
Di Stefano P, Damiano L, Cabodi S, Aramu
S, Tordella L, Praduroux A, Piva R, Cavallo F, Forni G, Silengo L,
et al: p140Cap protein suppresses tumour cell properties,
regulating Csk and Src kinase activity. EMBO J. 26:2843–2855. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kruh J: Effects of sodium butyrate, a new
pharmacological agent, on cells in culture. Mol Cell Biochem.
42:65–82. 1982.PubMed/NCBI
|
|
20
|
Candido EP, Reeves R and Davie JR: Sodium
butyrate inhibits histone deacetylation in cultured cells. Cell.
14:105–113. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davie JR: Inhibition of histone
deacetylase activity by butyrate. J Nutr. 133:2485S–2493S.
2003.PubMed/NCBI
|
|
22
|
Kopetz S, Morris VK, Parikh N, Overman MJ,
Jiang ZQ, Maru D, Elvin P and Gallick G: Src activity is modulated
by oxaliplatin and correlates with outcomes after hepatectomy for
metastatic colorectal cancer. BMC Cancer. 14:6602014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y, Guo Z, Zhang D, Zhang W, Yan Q, Shi
X, Zhang M, Zhao Y, Zhang Y, Jiang B, et al: A novel colon cancer
gene therapy using rAAV-mediated expression of human shRNA-FHL2.
Int J Oncol. 43:1618–1626. 2013.PubMed/NCBI
|
|
24
|
Zhang W, Jiang B, Guo Z, Sardet C, Zou B,
Lam CS, Li J, He M, Lan HY, Pang R, et al: Four-and-a-half LIM
protein 2 promotes invasive potential and epithelial-mesenchymal
transition in colon cancer. Carcinogenesis. 31:1220–1229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan Q, Zhang W, Wu Y, Wu M, Zhang M, Shi
X, Zhao J, Nan Q, Chen Y, Wang L, et al: KLF8 promotes
tumorigenesis, invasion and metastasis of colorectal cancer cells
by transcriptional activation of FHL2. Oncotarget. 6:25402–25417.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schneikert J, Grohmann A and Behrens J:
Truncated APC regulates the transcriptional activity of
beta-catenin in a cell cycle dependent manner. Hum Mol Genet.
16:199–209. 2007. View Article : Google Scholar
|
|
27
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kennedy S, Clynes M, Doolan P, Mehta JP,
Rani S, Crown J and O'Driscoll L: SNIP/p140Cap mRNA expression is
an unfavourable prognostic factor in breast cancer and is not
expressed in normal breast tissue. Br J Cancer. 98:1641–1645. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eves EM and Rosner MR: MAP kinase
regulation of the mitotic spindle checkpoint. Methods Mol Biol.
661:497–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stewénius Y, Gorunova L, Jonson T, Larsson
N, Höglund M, Mandahl N, Mertens F, Mitelman F and Gisselsson D:
Structural and numerical chromosome changes in colon cancer develop
through telomere-mediated anaphase bridges, not through mitotic
multipolarity. Proc Natl Acad Sci USA. 102:5541–5546. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Arsdale T, Boshoff C, Arndt KT and
Abraham RT: Molecular pathways: Targeting the cyclin D-CDK4/6 axis
for cancer treatment. Clin Cancer Res. 21:2905–2910. 2015.
View Article : Google Scholar
|
|
32
|
Kurokawa K, Akaike Y, Masuda K, Kuwano Y,
Nishida K, Yamagishi N, Kajita K, Tanahashi T and Rokutan K:
Downregulation of serine/arginine-rich splicing factor 3 induces G1
cell cycle arrest and apoptosis in colon cancer cells. Oncogene.
33:1407–1417. 2014. View Article : Google Scholar
|
|
33
|
Chan DW, Mak CS, Leung TH, Chan KK and
Ngan HY: Downregulation of Sox7 is associated with aberrant
activation of Wnt/b-catenin signaling in endometrial cancer.
Oncotarget. 3:1546–1556. 2012. View Article : Google Scholar
|
|
34
|
Sánchez-Bailón MP, Calcabrini A,
Gómez-Domínguez D, Morte B, Martín-Forero E, Gómez-López G,
Molinari A, Wagner KU and Martín-Pérez J: Src kinases catalytic
activity regulates proliferation, migration and invasiveness of
MDA-MB-231 breast cancer cells. Cell Signal. 24:1276–1286. 2012.
View Article : Google Scholar : PubMed/NCBI
|
